Statistician, Statistics Department, EORTC Headquarters
Michal Kicinski earned his Master of Science in Statistics, Specialization biostatistics, with great distinction from KU Leuven in 2011, Belgium, and his PhD in Science from Hasselt University, Belgium in 2015. As a researcher at Hasselt University, Michal conducted studies in the field of epidemiology, worked as a statistical consultant, performed research on methods to detect publication in meta-analysis, and investigated the size of publication bias in published meta-analyses. Michal joined the EORTC after obtaining his PhD. As a fellow, he worked on studies assessing the long-term outcomes among survivors of Hodgkin lymphoma and childhood ALL, studies comparing outcomes of patients treated in and outside clinical trials, a phase III melanoma trial comparing adjuvant pembrolizumab with placebo, and analyses of prognostic and predictive factors in childhood ALL and adult AML. Currently, Michal works as a biostatistician for the EORTC Leukemia, Children Leukemia, and Melanoma groups. In addition, he is involved in a study on methods to deal with crossover in analysis of overall survival and a study of methods to compare treatments when the hazards are non-proportional.